GLOBEALERT
Sign in
BUSINESS● LOWJul 20 · Jul 20, 2026, 2:12 AM

Samsung Biologics to acquire Switzerland's PolyPeptide Group in $1.8 billion all-cash deal

CNBC

South Korea's Samsung Biologics said on Monday that it had made an all-cash bid of 1.46 billion Swiss francs ($1.8 billion) for Switzerland's PolyPeptide Group.

Read at CNBC Ask the Analyst about this

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

See it on the live mapEvents around the world right now

More in Business

BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS5m agoSA analyst warns Fed hike could deepen stagflation fearsSeeking Alpha TechBUSINESS6m agoPSB Holdings declares $0.18 dividendSeeking Alpha Tech